April 18- U.S. drug distributor Cardinal Health Inc agreed to buy medical device maker Medtronic Plc's medical supplies units for $6.1 billion and said it expected full-year adjusted earnings at the lower end of its forecast. Cardinal Health, which had forecast adjusted profit in the range of $5.35- $5.50 per share, blamed generic price deflation for the...
April 18- U.S. drug distributor Cardinal Health Inc said on Tuesday it would buy medical device maker Medtronic Plc's medical supplies businesses for $6.1 billion in cash. Cardinal Health is acquiring the patient care, deep vein thrombosis and nutritional insufficiency units from Medtronic. Cardinal Health said it would finance the acquisition with cash...
Jim Cramer sees a hidden bull market in the fast-growing dental industry.
Carolin Roth discusses Roche's latest earnings data, and how new U.S. President Donald Trump will affect the pharmaceuticals industry.
CNBC's Meg Tirrell reports great strides are being made in monitoring abnormal heartbeats in patients.
AMSTERDAM, Jan 24- Medical equipment maker Philips missed forecasts for fourth-quarter earnings on Tuesday and disclosed a dispute with the U.S. Justice Department over heart defibrillators it had sold until 2016, but said the matter would not alter its medium term outlook. Van Houten said Philips' defibrillator business would be "impacted" but the scope was...
Organ transplants set new record in 2016. Sadly, it is due to a spike in deceased donors from drug overdoses.
Betadine-maker Mundipharma's new alliance with Manchester City all part of the pharma firm's EM strategy, the company told CNBC.
Mylan, Herbalife and T-Mobile are making headlines this Monday morning.
The pharmaceutical company will offer patients a two-pack carton at half price of the branded version.
Prescription drug prices are a mystery, but a new start up is disrupting prices for generic drugs across the country.
$21 billion is how much investors wiped off the firm after its trial to broaden the use of one of its most promising drugs failed.
Biotech startup NantHealth launched into the market Thursday after its initial public offering, with the stock surging nearly 33 percent.
A London start-up has invented a do-it-yourself DNA kit consumers can use to test the "athlete gene" — and other genetic identity markers.
A huge Hewlett Packard Enterprise project hopes to use massive data sets to better craft medical treatments and medicines for patients.
Scientists are one step closer in harnessing the power of genome sequencing to help improve the diagnosis and treatment of autism.
The Swiss pharmaceutical company struggles after a cheaper version of Gleevec launched in February.
With a grant from the Defense Department, a Florida medical center is creating a video game to train doctors for robotic surgery.
Michael Mussallem, Edwards Lifesciences CEO, talks about recent data on transcathether heart valves which show a minimally invasive procedure to replace the aortic heart valve is superior to open-heart surgery for patients with certain risks of complications.
It's hoped the FDA will approve an artificial pancreas in 2017. The device is expected to transform treatment of type 1 diabetes.